**Equity Swap Contract**

This contract is an equity swap agreement between Party A and Party B, entered into on September 24, 2001. The trade is identified by the global reference "33f59567" and the external reference "party1".

**Trade Details**

* Trade Date: September 24, 2001
* Effective Date: October 5, 2001
* Termination Date: October 5, 2033
* Mandatory Early Termination Date: November 3, 2001
* Notional Amount: USD 10,000,000

**Product Details**

* Product Type: Equity Swap
* Underlying Security: Shire Pharmaceuticals Group - American Depositary Receipts (SHPGY.O)
* Return Type: Total Return
* Dividend Return Terms:
	+ Dividend Payout Ratio: 100%
	+ Dividend Reinvestment: False
	+ Dividend Entitlement: Ex-Date
	+ Extraordinary Dividends Party: Extraordinary Dividends Party
	+ Excess Dividend Amount: Record Amount
	+ Dividend Currency: Determined by Dividend Currency
	+ Dividend Period: September 24, 2001 to October 5, 2033

**Payment Terms**

* Party A Payments:
	+ Party A pays (in USD): 4.427% p.a. on the Notional Amount
	+ Party A Calculation Period: October 5 to October 5 of each year
	+ Party A Payment Dates: Annually 2 Business Days after October 5 of each year
* Party B Payments:
	+ Party B pays (in USD): USD SOFR-COMPOUND p.a. on the Notional Amount
	+ Party B Calculation Period: October 5 to October 5 of each year
	+ Party B Payment Dates: Annually 2 Business Days after October 5 of each year

**Calculation Agent**

* Calculation Agent: Party A (unless stated otherwise in ISDA)

**Governing Law**

* Governing Law: English

**Documentation**

* Documentation: ISDA

**Risk Disclosure**

* There are significant risks associated with this Transaction, including foreign exchange risk, price risk, liquidity risk, and credit risk.

**Scenario Analysis**

* The following Scenario Analysis is provided for illustrative and convenience purposes only:
	+ Scenario 1: USD SOFR-COMPOUND remains unchanged over the tenor of the trade
	+ Scenario 2: USD SOFR-COMPOUND increases over the tenor of the trade
	+ Scenario 3: USD SOFR-COMPOUND decreases over the tenor of the trade

**Mark to Market (MTM) Sensitivity Analysis**

* The following MTM Analysis is provided for illustrative and convenience purposes only:
	+ MTM Sensitivity due to parallel shift in USD SOFR-COMPOUND Curve immediately after Trade Date
	+ MTM Sensitivity due to parallel shift in USD SOFR-COMPOUND Curve as on Mandatory Termination Date compared to Trade Date

**Level of Pricing Variables and Impact of Variables on Pricing**

* The following analysis is provided for information and illustrative purposes only:
	+ USD 10-year SOFR-COMPOUND Rate: 4.427%

**Representations**

* Each party represents to the other party that:
	+ They are acting for their own account and have made their own independent decisions to enter into this Transaction
	+ They are capable of assessing the merits of and understanding the terms, conditions, and risks of this Transaction
	+ They are not relying on any communication (written or oral) of the other party as investment advice or as a recommendation to enter into this Transaction

**Acceptance and Agreement**

* This contract is accepted and agreed upon by the parties as of the date of execution.